Talymus eye drops for spring catarrh treatment (VKC) from Japan

What are Talymus eye drops for spring catarrh (vernal keratoconjunctivitis, VKC)?

Talymus eye drops, containing tacrolimus hydrate, are effective for the treatment for spring catarrh, a chronic allergic eye condition characterized by inflammation and discomfort. The mechanism of action of these eye drops revolves around tacrolimus hydrate's immunosuppressive properties. Tacrolimus hydrate belongs to a class of drugs called calcineurin inhibitors, which work by inhibiting the activation of T cells, a crucial component of the immune response

In the context of spring catarrh, the allergic response is driven by an overactive immune system reacting to pollen and other environmental allergens. Tacrolimus hydrate in Talymus eye drops acts to modulate this immune response by reducing the release of inflammatory cytokines and dampening the activity of immune cells that contribute to the allergic reaction. This leads to a decrease in the inflammation, itching, and discomfort associated with spring catarrh.

Clinical studies have demonstrated the effectiveness of Talymus eye drops in managing spring catarrh. By targeting the underlying immune response, these eye drops provide relief from symptoms that often include redness, itching, watering, and photophobia. Additionally, because they act directly on the site of inflammation (the eye), they minimize systemic side effects commonly associated with oral immunosuppressive medications.

The localized application of Tacrolimus hydrate via Talymus eye drops also aids in minimizing systemic absorption, reducing the risk of systemic side effects.

Active principles: tacrolimus hydrate

Amount: 5 ml

Maker: Senju Pharmaceutical Co., Ltd., Osaka, Japan

Indications: treatment of spring catarrh (vernal keratoconjunctivitis, VKC)

How to use

Gently shake the medicine bottle before each use. Generally, apply 1 drop at a time, 2 times a day. 

Prior to usage, cleanse your hands using soap and water. Next, ensure a thorough shaking of the bottle and proceed to uncap it. Administer the medicine while ensuring the dropper's tip does not come into contact with your eye's surface. Following instillation, close your eyes for a period of 1 to 5 minutes, softly applying pressure to the inner corner of your eye using your fingertip. Any excess liquid can be wiped away using a clean gauze or tissue. If you need to use of other eye drops simultaneously, ensure a waiting period of more than 5 minutes.

Contraindications: do not use for pregnant or breastfeeding women. Do not use for patients with glaucoma or eye infection. 

Important information

The bottle's film (except the cap) has a light-blocking effect. Do not remove this protective film.

Store the bottle in an upright position to control the even distribution of the powder in the medicine. 

Do not use this medicine while wearing contact lenses. You should take off the lenses before applying the medicine and wear them again not earlier than 15-20 minutes after applying. 

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.